Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis

NCT04384692 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
53
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fred Hutchinson Cancer Center